Urania Dafni

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules

Dimitris Karlis, Xanthi Pedeli, Christoph C Zielinski, 2017, ESMO Open.

Usefulness of Tumor Volumetry as a Prognostic Factor of Survival in Head and Neck Cancer

George Fountzilas, Urania Dafni, Nikolaos Zamboglou, 2003, Strahlentherapie und Onkologie.

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

Urania Dafni, U. Dafni, E. D. de Vries, 2016, Oncotarget.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.

Mitch Dowsett, Marion Procter, Brian Leyland-Jones, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer

George Fountzilas, Tudor Ciuleanu, Thomas Zaraboukas, 2004, Medical oncology.

Planning syndromic surveillance for the Athens 2004 Olympic games: A pilot study

Urania Dafni, George Saroglou, Sotirios Tsiodras, 2006, Journal of Urban Health.